Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Morning After The Inauguration: No Plan B Decision

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency was unable to reach a decision on Barr’s application for an OTC switch of the emergency contraceptive by the Jan. 21 user fee date; Barr expects a decision from FDA “in the near future.”
Advertisement

Related Content

Plan B Headed For Behind-The-Counter Sale
Plan B Headed For Behind-The-Counter Sale
Senate Health Democrats Press FDA’s Crawford For Plan B Decision Timeline
Senate Health Democrats Press FDA’s Crawford For Plan B Decision Timeline
Barr's Plan B OTC Switch User Fee Date Arrives Jan. 21
Barr's Plan B OTC Switch User Fee Date Arrives Jan. 21
Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock

Topics

Advertisement
UsernamePublicRestriction

Register

PS060920

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel